PEACE-2 finds adding cabazitaxel to ADT plus radiotherapy fails to improve survival in high-risk localized prostate cancer, while increasing severe toxicities and deaths.
(PTx) announced findings from a post hoc analysis of the eNRGy trial (NCT02912949) evaluating treatment beyond progression with zenocutuzumab in patients with advanced neuregulin 1 fusion-positive ...
Ten percent complete response and rapid, durable antitumor activity reported with RYBREVANT FASPRO; results surpass current standards of care RARITAN, N.J., Feb. 19 ...
Johnson & Johnson today announced new results from the Phase 1b/2 OrigAMI-4 study showing that first-line treatment with investigational subcutaneous amivantamab and hyaluronidase-lpuj in combination ...
Johnson & Johnson (NYSE: JNJ) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) for subcutaneous amivantamab and hyaluronidase-lpuj as ...
New designation is based on data showing rapid and durable responses in a heavily pretreated patient population and expands the promise of RYBREVANT FASPRO beyond lung ...
Scientists identify a DNA methylation alcohol biomarker that tracks exposure and aging signals, offering new insight into how drinking patterns may shape long-term health. Study: Alcohol Consumption ...
The round includes a secondary raise providing early employees with liquidity, recognizing the team’s role in building Gamma’s success SAN FRANCISCO--(BUSINESS WIRE)--Gamma, the fastest-growing AI ...
There are more than a few ways to gain superpowers in the Marvel Cinematic Universe. The most common method appears to be some form of the super soldier serum, as nearly a dozen characters in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results